Sponsor

Chromaderm, Inc.

Clinical research sponsor

Published trials10

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

10 shown

Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes MellitusNCT00297401 · lead sponsor · 2006-03-01

COMPLETED

Treatment for Completers of the Study B7A-MC-MBCMNCT00266695 · lead sponsor · 2006-01-01

COMPLETED

Effect of Ruboxistaurin on Clinically Significant Macular EdemaNCT00133952 · lead sponsor · 2005-08-01

COMPLETED

The Effect of Ruboxistaurin on Small Fiber FunctionNCT00190970 · lead sponsor · 2004-10-01

COMPLETED

Reduction in the Occurrence of Center-Involved Diabetic Macular EdemaNCT00090519 · lead sponsor · 2004-02-01

COMPLETED

Effect of LY333531 on Vascular and Neural FunctionsNCT00482976 · lead sponsor · 2003-12-01

COMPLETED

Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes MellitusNCT00552227 · lead sponsor · 2002-09-01

COMPLETED

The Effect of LY333531 on Protein in the Urine in Patients With Type 2 DiabetesNCT00044148 · lead sponsor · 2002-07-16

COMPLETED

Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesNCT00044408 · lead sponsor · 2002-07-01

COMPLETED

Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 StudyNCT00604383 · lead sponsor · 2001-03-01

COMPLETED

Sponsor roles

lead sponsor10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.